Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccination effects on hematopoietic stem cells and bone marrow immunity
NL-OMON24361Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of bcg vaccine in Tuberculosis (TB) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Cellular composition of the bone marrow, Ex vivo differentiation of hematopoietic stem and progenitor cells and 1 more. Started Dec 2016; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NL-OMON24361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24361.